Search

everythinglearnresearchcommunity

for

Search:↓

Oral minoxidil is as effective and safe as topical minoxidil for treating female pattern hair loss.

Diphenylcyclopropenone is more effective and has fewer side effects than dinitrochlorobenzene for treating alopecia areata.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Lenalidomide effectively and safely treats skin symptoms in pediatric lupus, reducing the need for prednisone.

A shampoo with cannabidiol can significantly reduce scalp inflammation and symptoms in people with mild to moderate psoriasis or seborrheic dermatitis.

Early diagnosis and hormone therapy can significantly improve outcomes for post-partum pituitary insufficiency in resource-limited settings.

Treat limited stage small cell lung cancer with chemotherapy and radiation, and consider preventive brain radiation for better survival chances.

Six African American women experienced hair loss after switching to a new HIV medication.

A woman had a severe skin reaction from the drug imiquimod, used for skin cancer, highlighting the need for awareness of rare but serious side effects.

A woman had a delayed allergic reaction to the blood thinner enoxaparin, treated with a steroid cream.

A man developed a rare skin condition and drug-induced lupus, highlighting the need for biopsy in diagnosing skin issues caused by sunlight.

Pioglitazone usually doesn't effectively treat or cure lichen planopilaris.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

ALDOA levels drop in hair cells during hair loss.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

The transscrotal testosterone patch normalizes hormone levels in men with AIDS and weight loss but does not improve weight, body mass, or quality of life.

People with polycystic ovary syndrome have a higher chance of having chronic thyroiditis.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

Cyclophosphamide has serious side effects, but long-term follow-up can help manage risks.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

People with alopecia areata often have higher rates of allergies and autoimmune diseases.

Post-finasteride syndrome causes lasting sexual, neurological, and physical side effects in some people after taking finasteride.

Topical contact sensitizers can treat certain skin conditions but are rarely used in the U.K.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

A man had an allergic reaction to minoxidil, which stopped after he discontinued use and started corticosteroids.

Interferon gamma alone can't cause alopecia areata in C3H/HeJ mice.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Actinic superficial folliculitis is a unique skin condition caused by intense heat and sweating.